← Back to Search
The Effect Of Coenzyme Q10 Supplementation On Serum Levels Of Lactate, Pyruvate, Matrix Metalloproteinase 9 And Nitric Oxide In Women With Migraine. A Double Blind, Placebo, Controlled Randomized Clinical Trial
Elyas Nattagh-Eshtivani, M. Dahri, M. Hashemilar, A. Tarighat-Esfanjani
Published 2018 · Medicine
Save to my Library
Download PDFAnalyze on Scholarcy
Abstract Introduction Coenzyme Q10 (CoQ10), as a supplement with a special role in mitochondrial electron transport chain, could be used as a successful migraine preventative therapy. The purpose of this study was to investigate the effect of CoQ10 supplementation on lactate, pyruvate, Matrix metalloproteinase 9 (MMP-9) and nitric oxide (NO) levels in addition to migraine attacks in women with migraine. Methods This randomized, double-blind, placebo-controlled clinical trial was performed among 46 patients diagnosed with migraine. Subjects were randomly assigned to placebo group (n = 23) and/or intervention group (n = 23), supplemented with 400 mg/day of CoQ10. The duration of the intervention was 12 weeks. Blood samples were collected at baseline and at the end of the intervention, in order to measure serum levels of CoQ10, lactate, pyruvate, MMP-9 and NO. Results Treatment with CoQ10 significantly reduced serum concentrations of lactate, pyruvate, MMP-9 and NO while CoQ10 concentrations increased after 12 weeks (p 0.05). The results of this study showed that CoQ10 supplementation significantly decreased frequency, severity and duration of migraine attacks compared with placebo receiving group (p Conclusion In the current trial, 12 weeks of oral CoQ10 supplementation demonstrated positive effects on control of migraine attacks, mitochondrial function, serum levels of NO and MMP-9 as an involvement factors in the pathophysiology of migraines.
This paper references
Evaluation of anti‐angiogenic, anti‐inflammatory and antinociceptive activity of coenzyme Q10 in experimental animals
H. Jung (2009)
Magnetic Resonance Spectroscopy Studies in Migraine
P. Montagna (1994)
Hyperinsulinaemia in migraineurs is associated with nitric oxide stress
H. Gruber (2010)
Increased asymmetric dimethylarginine and nitric oxide levels in patients with migraine
E. Uzar (2011)
Coenzyme Q10 Depletion in Medical and Neuropsychiatric Disorders: Potential Repercussions and Therapeutic Implications
G. Morris (2013)
Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects.
R. Matthews (1998)
Lipid-lowering drugs and mitochondrial function: effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratio.
G. de Pinieux (1996)
Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
T. Vos (2016)
The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache.
J. Olesen (2008)
The role of nitric oxide in nociception
Z. Luo (2000)
A randomized, double-blinded, placebo-controlled, crossover, add-on study of CoEnzyme Q10 in the prevention of pediatric and adolescent migraine
S. Slater (2011)
Oxidative Stress in Migraine with and Without Aura
D. Tuncel (2008)
Increased Plasma Matrix Metalloproteinase‐9 Levels in Migraineurs
K. Imamura (2008)
Open Label Trial of Coenzyme Q10 as A Migraine Preventive
T. Rozen (2002)
SUPPLEMENTED WITH COQ10: THE ROLE OF NITRIC OXIDE METABOLITES (NOX) ON BLOOD PRESSURE LEVELS IN TYPE 2 DIABETIC PATIENTS
R. Mohammadi (2014)
Potential Beneficial Effects of Probiotics on Human Migraine Headache: A Literature Review.
Yu-jie Dai (2017)
Different circulating metalloproteinases profiles in women with migraine with and without aura.
A. Martins-Oliveira (2009)
Changes in plasma nitric oxide levels during migraine initial and attack periods in migraine patients
U. Ozbey (2013)
Cerebrospinal-fluid abnormalities associated with migraine.
T. Day (1984)
Mediterranean diet supplemented with coenzyme Q10 modifies the expression of proinflammatory and endoplasmic reticulum stress-related genes in elderly men and women.
E. Yubero-Serrano (2012)
Mitochondrial Dysfunction and Migraine
M. Sparaco (2006)
Coenzyme Q10 Deficiency and Response to Supplementation in Pediatric and Adolescent Migraine
A. Hershey (2007)
Hepatoprotective effect of coenzyme Q10 in rats with acetaminophen toxicity.
A. Fouad (2012)
Mitochondrial dysfunction in migraine.
William R Yorns (2013)
Oral coenzyme Q10 supplementation in patients with migraine: Effects on clinical features and inflammatory markers
M. Dahri (2018)
Riboflavin prophylaxis in pediatric and adolescent migraine
Maria Condò (2009)
The role of nutrients in the pathogenesis and treatment of migraine headaches: Review.
Elyas Nattagh-Eshtivani (2018)
Habitual physical activity is associated with endothelial function and endothelial progenitor cells in patients with stable coronary artery disease
Ting-Hin Luk (2009)
Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases
J. Hu (2007)
EFFECTS OF ORAL MAGNESIUM FOR MIGRAINE PROPHYLAXIS
R. Mahdavi (2009)
Preventive non–pharmacological treatment and nitric oxide in chronic migraine
I. Ciancarelli (2005)
Safety assessment of coenzyme Q10 (Kaneka Q10) in healthy subjects: a double-blind, randomized, placebo-controlled trial.
H. Ikematsu (2006)
A possible role for mitochondrial dysfunction in migraine
S. Stuart (2012)
Double contrast barium enema combined with non-invasive imaging in peritoneal mesothelioma.
G. Cozzi (1989)
Increased nitrosative and oxidative stress in platelets of migraine patients.
Gülşen Yılmaz (2007)
Mitochondrial Abnormalities in Migraine. Preliminary Findings.
P. Montagna (1988)
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
K. Kessenbrock (2010)
Cortical spreading depression activates and upregulates MMP-9.
Y. Gursoy-Ozdemir (2004)
Serum Lactic Acid and Pyruvic Acid Levels in Patients with Migraine and Tension Type Headache
Y. Altunkaynak (2013)
Exogenous coenzyme Q10 modulates MMP-2 activity in MCF-7 cell line as a breast cancer cellular model
M. Bahar (2010)
MMP‐9 Immunoreactivity in Acute Migraine
R. Leira (2007)
Reversal of mitochondrial dysfunction by coenzyme Q10 supplement improves endothelial function in patients with ischaemic left ventricular systolic dysfunction: a randomized controlled trial.
Yuk-Ling Dai (2011)
Nitric oxide-induced mitochondrial dysfunction: implications for neurodegeneration.
V. Stewart (2003)
Specific matrix metalloproteinase 9 (MMP-9) haplotype affect the circulating MMP-9 levels in women with migraine
A. Martins-Oliveira (2012)
Nitric oxide-related drag targets in headache
J. Olesen (2011)
Matrix metalloproteinase (MMP)-2 gene polymorphisms affect circulating MMP-2 levels in patients with migraine with aura.
F. M. Gonçalves (2013)
Coenzyme Q10 Protects the Aging Heart against Stress
F. Rosenfeldt (2002)
The Effects of Magnesium, l-Carnitine, and Concurrent Magnesium–l-Carnitine Supplementation in Migraine Prophylaxis
Ali Tarighat Esfanjani (2012)
Efficacy of coenzyme Q10 for the prevention of migraine in women: A randomized, double-blind, placebo-controlled study
M. Dahri (2017)
Coenzyme Q10 supplementation lowers hepatic oxidative stress and inflammation associated with diet-induced obesity in mice.
Florence M. Sohet (2009)
Risk assessment for coenzyme Q10 (Ubiquinone).
J. Hathcock (2006)
Antiangiogenic and hypolipidemic activity of coenzyme Q10 supplementation to breast cancer patients undergoing Tamoxifen therapy
P. Sachdanandam (2008)
Determination of the blood lactate:pyruvate ratio as a noninvasive test for the diagnosis of zidovudine myopathy.
P. Chariot (1994)
High‐dose riboflavin treatment is efficacious in migraine prophylaxis: an open study in a tertiary care centre
C. Boehnke (2004)
The effect of the use of coenzyme Q10 on lactic acid and total antioxidant capacity in professional skiers.
N. Demirci (2013)
Efficacy of coenzyme Q10 in migraine prophylaxis: A randomized controlled trial
P. Sándor (2005)
Ubiquinone and nicotinamide treatment of patients with the 3243A→G mtDNA mutation
A. Remes (2002)
Coenzyme Q10 supplementation ameliorates inflammatory markers in patients with multiple sclerosis: a double blind, placebo, controlled randomized clinical trial
Meisam Sanoobar (2015)
Hemodynamic studies within the brain during migraine.
E. Skinhøj (1973)
This paper is referenced by
Coenzyme Q10 supplementation and oxidative stress parameters: a systematic review and meta-analysis of clinical trials
Abolfazl Akbari (2020)